LucidScope
AI is already answering questions about your brand. LucidScope shows you what it’s saying, and why.
LucidScope evaluates how leading AI systems respond to real-world questions about your company, products, indications, and competitors.
It maps visibility and positioning in AI-generated answers, traces the sources shaping those answers, and highlights gaps where evidence is missing, outdated, or misrepresented.
What you can do with LucidScope:
-
Perception Mapping: Compare how AI positions your brand versus key competitors.
- See how AI frames your brand versus competitors, by theme and attribute.
-
Answers Mapping: See how models answer the same stakeholder questions, and where they diverge.
- View side-by-side model answers to your key questions, with differences highlighted.
-
Source Tracing: Identify which websites and documents are shaping AI answers, and where to intervene.
- Understand which domains and documents drive the answers, and what’s missing.
-
Launch and campaign monitoring: Track changes over time across models, markets, and topics.
- Monitor shifts in positioning, key claims, and cited sources (you vs competitors).
LucidScope is part of LucidQuest’s intelligence stack, complementing our primary research, conference coverage, and wargaming capabilities.
Combined with NexusBrain (nexusbrain.io), LucidScope insights can be mapped alongside your team’s own field observations to give a complete picture of how AI is shaping your brand’s perception.
Want to see what AI is saying about your brand? Request an AI Answer Audit.
You’ll receive a short report covering Perception, Answers, Source Tracing, and Zero-click gaps.
Already evaluating tools? Test LucidScope.
Questions or feedback? Email us anytime.
July 1, 2026
How AI Models Are Shaping Perceptions of Cystic Fibrosis Therapies | LucidScope AI Visibility Audit
July 1, 2026
Neuroscience Today—July 1, 2026
July 1, 2026
Immunology Today—July 1, 2026
June 30, 2026
Innovent-Lilly Verzenios China Commercialization | Lucid Diligence Brief
June 30, 2026
Sickle Cell Gene Therapies Ranked by AI Models | LucidScope AI Visibility Audit
June 30, 2026
Endocrinology Today—June 30, 2026
June 30, 2026
Obesity Today—June 30, 2026
June 30, 2026
Endocrinology Today—June 23, 2026
June 29, 2026
Hematology Today—June 29, 2026
June 29, 2026
Oncology Today—June 29, 2026
June 29, 2026
Merck KGaA Bio-Techne Deal | Lucid Diligence Brief
June 26, 2026